Copyright Reports & Markets. All rights reserved.

Global Peptide-based Drug Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Peptide-based Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Injection
    • 1.2.3 Oral
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Peptide-based Drug Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Cancer
    • 1.3.3 Metabolic Disorders
    • 1.3.4 Central Nervous System
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Peptide-based Drug Market Perspective (2016-2027)
  • 2.2 Peptide-based Drug Growth Trends by Regions
    • 2.2.1 Peptide-based Drug Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Peptide-based Drug Historic Market Share by Regions (2016-2021)
    • 2.2.3 Peptide-based Drug Forecasted Market Size by Regions (2022-2027)
  • 2.3 Peptide-based Drug Industry Dynamic
    • 2.3.1 Peptide-based Drug Market Trends
    • 2.3.2 Peptide-based Drug Market Drivers
    • 2.3.3 Peptide-based Drug Market Challenges
    • 2.3.4 Peptide-based Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Peptide-based Drug Players by Revenue
    • 3.1.1 Global Top Peptide-based Drug Players by Revenue (2016-2021)
    • 3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2016-2021)
  • 3.2 Global Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Peptide-based Drug Revenue
  • 3.4 Global Peptide-based Drug Market Concentration Ratio
    • 3.4.1 Global Peptide-based Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Peptide-based Drug Revenue in 2020
  • 3.5 Peptide-based Drug Key Players Head office and Area Served
  • 3.6 Key Players Peptide-based Drug Product Solution and Service
  • 3.7 Date of Enter into Peptide-based Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide-based Drug Breakdown Data by Type

  • 4.1 Global Peptide-based Drug Historic Market Size by Type (2016-2021)
  • 4.2 Global Peptide-based Drug Forecasted Market Size by Type (2022-2027)

5 Peptide-based Drug Breakdown Data by Application

  • 5.1 Global Peptide-based Drug Historic Market Size by Application (2016-2021)
  • 5.2 Global Peptide-based Drug Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Peptide-based Drug Market Size (2016-2027)
  • 6.2 North America Peptide-based Drug Market Size by Type
    • 6.2.1 North America Peptide-based Drug Market Size by Type (2016-2021)
    • 6.2.2 North America Peptide-based Drug Market Size by Type (2022-2027)
    • 6.2.3 North America Peptide-based Drug Market Size by Type (2016-2027)
  • 6.3 North America Peptide-based Drug Market Size by Application
    • 6.3.1 North America Peptide-based Drug Market Size by Application (2016-2021)
    • 6.3.2 North America Peptide-based Drug Market Size by Application (2022-2027)
    • 6.3.3 North America Peptide-based Drug Market Size by Application (2016-2027)
  • 6.4 North America Peptide-based Drug Market Size by Country
    • 6.4.1 North America Peptide-based Drug Market Size by Country (2016-2021)
    • 6.4.2 North America Peptide-based Drug Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Peptide-based Drug Market Size (2016-2027)
  • 7.2 Europe Peptide-based Drug Market Size by Type
    • 7.2.1 Europe Peptide-based Drug Market Size by Type (2016-2021)
    • 7.2.2 Europe Peptide-based Drug Market Size by Type (2022-2027)
    • 7.2.3 Europe Peptide-based Drug Market Size by Type (2016-2027)
  • 7.3 Europe Peptide-based Drug Market Size by Application
    • 7.3.1 Europe Peptide-based Drug Market Size by Application (2016-2021)
    • 7.3.2 Europe Peptide-based Drug Market Size by Application (2022-2027)
    • 7.3.3 Europe Peptide-based Drug Market Size by Application (2016-2027)
  • 7.4 Europe Peptide-based Drug Market Size by Country
    • 7.4.1 Europe Peptide-based Drug Market Size by Country (2016-2021)
    • 7.4.2 Europe Peptide-based Drug Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Peptide-based Drug Market Size (2016-2027)
  • 8.2 Asia-Pacific Peptide-based Drug Market Size by Type
    • 8.2.1 Asia-Pacific Peptide-based Drug Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Peptide-based Drug Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Peptide-based Drug Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Peptide-based Drug Market Size by Application
    • 8.3.1 Asia-Pacific Peptide-based Drug Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Peptide-based Drug Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Peptide-based Drug Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Peptide-based Drug Market Size by Region
    • 8.4.1 Asia-Pacific Peptide-based Drug Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Peptide-based Drug Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Peptide-based Drug Market Size (2016-2027)
  • 9.2 Latin America Peptide-based Drug Market Size by Type
    • 9.2.1 Latin America Peptide-based Drug Market Size by Type (2016-2021)
    • 9.2.2 Latin America Peptide-based Drug Market Size by Type (2022-2027)
    • 9.2.3 Latin America Peptide-based Drug Market Size by Type (2016-2027)
  • 9.3 Latin America Peptide-based Drug Market Size by Application
    • 9.3.1 Latin America Peptide-based Drug Market Size by Application (2016-2021)
    • 9.3.2 Latin America Peptide-based Drug Market Size by Application (2022-2027)
    • 9.3.3 Latin America Peptide-based Drug Market Size by Application (2016-2027)
  • 9.4 Latin America Peptide-based Drug Market Size by Country
    • 9.4.1 Latin America Peptide-based Drug Market Size by Country (2016-2021)
    • 9.4.2 Latin America Peptide-based Drug Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Peptide-based Drug Market Size (2016-2027)
  • 10.2 Middle East & Africa Peptide-based Drug Market Size by Type
    • 10.2.1 Middle East & Africa Peptide-based Drug Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Peptide-based Drug Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Peptide-based Drug Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Peptide-based Drug Market Size by Application
    • 10.3.1 Middle East & Africa Peptide-based Drug Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Peptide-based Drug Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Peptide-based Drug Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Peptide-based Drug Market Size by Country
    • 10.4.1 Middle East & Africa Peptide-based Drug Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Peptide-based Drug Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Company Details
    • 11.1.2 Sanofi Business Overview
    • 11.1.3 Sanofi Peptide-based Drug Introduction
    • 11.1.4 Sanofi Revenue in Peptide-based Drug Business (2016-2021)
    • 11.1.5 Sanofi Recent Development
  • 11.2 Teva
    • 11.2.1 Teva Company Details
    • 11.2.2 Teva Business Overview
    • 11.2.3 Teva Peptide-based Drug Introduction
    • 11.2.4 Teva Revenue in Peptide-based Drug Business (2016-2021)
    • 11.2.5 Teva Recent Development
  • 11.3 Novo Nordisk
    • 11.3.1 Novo Nordisk Company Details
    • 11.3.2 Novo Nordisk Business Overview
    • 11.3.3 Novo Nordisk Peptide-based Drug Introduction
    • 11.3.4 Novo Nordisk Revenue in Peptide-based Drug Business (2016-2021)
    • 11.3.5 Novo Nordisk Recent Development
  • 11.4 Takeda
    • 11.4.1 Takeda Company Details
    • 11.4.2 Takeda Business Overview
    • 11.4.3 Takeda Peptide-based Drug Introduction
    • 11.4.4 Takeda Revenue in Peptide-based Drug Business (2016-2021)
    • 11.4.5 Takeda Recent Development
  • 11.5 Eli Lilly
    • 11.5.1 Eli Lilly Company Details
    • 11.5.2 Eli Lilly Business Overview
    • 11.5.3 Eli Lilly Peptide-based Drug Introduction
    • 11.5.4 Eli Lilly Revenue in Peptide-based Drug Business (2016-2021)
    • 11.5.5 Eli Lilly Recent Development
  • 11.6 AstraZeneca
    • 11.6.1 AstraZeneca Company Details
    • 11.6.2 AstraZeneca Business Overview
    • 11.6.3 AstraZeneca Peptide-based Drug Introduction
    • 11.6.4 AstraZeneca Revenue in Peptide-based Drug Business (2016-2021)
    • 11.6.5 AstraZeneca Recent Development
  • 11.7 Novartis
    • 11.7.1 Novartis Company Details
    • 11.7.2 Novartis Business Overview
    • 11.7.3 Novartis Peptide-based Drug Introduction
    • 11.7.4 Novartis Revenue in Peptide-based Drug Business (2016-2021)
    • 11.7.5 Novartis Recent Development
  • 11.8 AbbVie
    • 11.8.1 AbbVie Company Details
    • 11.8.2 AbbVie Business Overview
    • 11.8.3 AbbVie Peptide-based Drug Introduction
    • 11.8.4 AbbVie Revenue in Peptide-based Drug Business (2016-2021)
    • 11.8.5 AbbVie Recent Development
  • 11.9 Ipsen
    • 11.9.1 Ipsen Company Details
    • 11.9.2 Ipsen Business Overview
    • 11.9.3 Ipsen Peptide-based Drug Introduction
    • 11.9.4 Ipsen Revenue in Peptide-based Drug Business (2016-2021)
    • 11.9.5 Ipsen Recent Development
  • 11.10 Ferring
    • 11.10.1 Ferring Company Details
    • 11.10.2 Ferring Business Overview
    • 11.10.3 Ferring Peptide-based Drug Introduction
    • 11.10.4 Ferring Revenue in Peptide-based Drug Business (2016-2021)
    • 11.10.5 Ferring Recent Development
  • 11.11 Merck
    • 11.11.1 Merck Company Details
    • 11.11.2 Merck Business Overview
    • 11.11.3 Merck Peptide-based Drug Introduction
    • 11.11.4 Merck Revenue in Peptide-based Drug Business (2016-2021)
    • 11.11.5 Merck Recent Development
  • 11.12 The Medicines
    • 11.12.1 The Medicines Company Details
    • 11.12.2 The Medicines Business Overview
    • 11.12.3 The Medicines Peptide-based Drug Introduction
    • 11.12.4 The Medicines Revenue in Peptide-based Drug Business (2016-2021)
    • 11.12.5 The Medicines Recent Development
  • 11.13 J & J
    • 11.13.1 J & J Company Details
    • 11.13.2 J & J Business Overview
    • 11.13.3 J & J Peptide-based Drug Introduction
    • 11.13.4 J & J Revenue in Peptide-based Drug Business (2016-2021)
    • 11.13.5 J & J Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Peptide-based Drug Scope and Market Size
    Peptide-based Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide-based Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Injection
    Oral
    Other

    Segment by Application
    Cancer
    Metabolic Disorders
    Central Nervous System
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Sanofi
    Teva
    Novo Nordisk
    Takeda
    Eli Lilly
    AstraZeneca
    Novartis
    AbbVie
    Ipsen
    Ferring
    Merck
    The Medicines
    J & J

    Buy now